Study on reducing injection pain with a device
Part of Pain clinical trials.
This trial tests a device called Shotblocker to see if it can reduce pain from intramuscular injections in adults. It may help if you need an injection in the emergency room.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and speak Turkish.
- Agree to participate by signing a consent form.
- Be in the emergency room needing a specific painkiller injection.
- Not be pregnant.
- Not have any psychiatric, hearing, or vision problems.
- Not have an infection or injury at the injection site.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a device called ShotBlocker—which applies gentle pressure to your skin—can reduce pain, anxiety, and discomfort when a nurse places an intravenous (IV) catheter in your arm. If you need an IV line placed, this trial explores whether the device makes the experience less painful.
This study tests two methods to reduce pain and fear during a shot in the emergency department. It compares using a vibration device or a ShotBlocker device against standard care.
This trial tests non-drug methods to reduce pain and fear when you get a hormone injection for breast cancer treatment. The goal is to help you feel more comfortable during the shot.
This study tests whether using simple distraction techniques during a shot can reduce pain in teenage girls who come to the emergency room with severe menstrual cramps.
This study tests two different injection methods (TPR and Z-track) to see if they cause less pain and less medication leakage when giving the painkiller diclofenac sodium into the hip muscle.
This study tests a special muscle-release technique during an intramuscular shot to see if it hurts less and makes patients more satisfied.
Hear when a new Patients Above 18 Years trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.